Serono Under Attack [Fool.com: Motley Fool Take] July 27, 2006
Serono Under Attack
By Brian Lawler (TMFBreakerBrian)
July 27, 2006
When I was growing up, I was always the last kid picked to play on the dodgeball court. So when biopharmaceutical company Serono (NYSE: SRA) put itself up for sale last year and nobody bought it, I could really empathize.
After you see Serono's second-quarter earnings numbers, which came out on Wednesday, you understand why the company wanted to sell itself last year. The numbers weren't terrible, but competitive pressures loom large for the future.
More
By Brian Lawler (TMFBreakerBrian)
July 27, 2006
When I was growing up, I was always the last kid picked to play on the dodgeball court. So when biopharmaceutical company Serono (NYSE: SRA) put itself up for sale last year and nobody bought it, I could really empathize.
After you see Serono's second-quarter earnings numbers, which came out on Wednesday, you understand why the company wanted to sell itself last year. The numbers weren't terrible, but competitive pressures loom large for the future.
More
posted by Bill Austin - Serono Under Attack [Fool.com: Motley Fool Take] July 27, 2006
0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home